Ildikó Csóka

Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives

Zsófia Németh, Ildikó Csóka, Reza Semnani Jazani et al. · Pharmaceutics · 2022 · 386 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation

Edina Pallagi, Rita Ambrus, Piroska Szabó‐Révész et al. · International Journal of Pharmaceutics · 2015 · 114 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine Development

Ildikó Csóka, Ruba Ismail, Orsolya Jójárt‐Laczkovich et al. · Current Medicinal Chemistry · 2021 · 112 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary

Béla Merkely, Attila J. Szabó, Annamária Kosztin et al. · GeroScience · 2020 · 100 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +13

Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method

Á. Kovács, Szilvia Berkó, Erzsébet Csányi et al. · European Journal of Pharmaceutical Sciences · 2016 · 76 citations

Pharmacy, Bioengineering, Pharmaceutics +17